(Q51814993)

13 April 2018

title

Raloxifene prevents endothelial dysfunction in aging ovariectomized female rats. (English)

1 reference

13 April 2018

0 references

6

1 reference

13 April 2018

Paul Michel Georges Remi Vanhoutte

7

object named as

Paul M Vanhoutte

1 reference

13 April 2018

Chi Ming Wong

1

1 reference

13 April 2018

Xiaoqiang Yao

2

1 reference

13 April 2018

Chak Leung Au

3

1 reference

13 April 2018

Suk Ying Tsang

4

1 reference

13 April 2018

Kwok Pui Fung

5

1 reference

13 April 2018

Yu Huang

8

1 reference

13 April 2018

publication date

15 March 2006

1 reference

13 April 2018

published in

Vascular Pharmacology

1 reference

13 April 2018

volume

44

1 reference

13 April 2018

issue

5

1 reference

13 April 2018

page(s)

290-298

1 reference

13 April 2018

Estrogen research. The great estrogen conundrum

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Characterization of an animal model of postmenopausal hypertension in spontaneously hypertensive rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Vasomotor and vascular effects of hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Basal release of nitric oxide from aortic rings is greater in female rabbits than in male rabbits: implications for atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Effect of raloxifene on the ovarian circulation in women after menopause

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

The Molecular Pharmacology of SERMs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Long-term effects of ovariectomy and estrogen replacement treatment on endothelial function in mature rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Postmenopausal oestrogen treatment and stroke: a prospective study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Raloxifene, an oestrogen-receptor modulator, prevents decreased constitutive nitric oxide and vasoconstriction in ovariectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Selective estrogen-receptor modulators -- mechanisms of action and application to clinical practice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma no concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Nongenomic mechanisms of endothelial nitric oxide synthase activation by the selective estrogen receptor modulator raloxifene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Vascular endothelial dysfunction in aging: loss of Akt-dependent endothelial nitric oxide synthase phosphorylation and partial restoration by (R)-alpha-lipoic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Gender differences in protein kinase G-mediated vasorelaxation of rat aorta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Hyper-reactivity of cerebral arteries from ovariectomized rats: therapeutic benefit of tamoxifen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Endothelial dysfunction and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Endothelium-dependent contractions in hypertension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

Raloxifene improves endothelial dysfunction in hypertension by reduced oxidative stress and enhanced nitric oxide production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

A diffusible substance(s) mediates endothelium-dependent contractions in the aorta of SHR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VPH.2005.12.005

10.1016/J.VPH.2005.12.005

7 January 2021

Identifiers

DOI

1 reference

13 April 2018

1 reference

13 April 2018